Literature DB >> 27113550

Vertebral Implantation of NELL-1 Enhances Bone Formation in an Osteoporotic Sheep Model.

Aaron W James1,2,3, Michael Chiang2, Greg Asatrian2, Jia Shen1,2, Raghav Goyal2, Choon G Chung2, Le Chang1,2, Swati Shrestha1,2, A Simon Turner4, Howard B Seim4, Xinli Zhang1,2, Benjamin M Wu5, Kang Ting1,2, Chia Soo1,6.   

Abstract

BACKGROUND: Vertebral compression fractures related to osteoporosis greatly afflict the aging population. One of the most commonly used therapy today is balloon kyphoplasty. However, this treatment is far from ideal and is associated with significant side effects. NELL-1, an osteoinductive factor that possesses both pro-osteogenic and anti-osteoclastic properties, is a promising candidate for an alternative to current treatment modalities. This study utilizes the pro-osteogenic properties of recombinant human NELL-1 (rhNELL-1) in lumbar spine vertebral defect model in osteoporotic sheep.
METHODS: Osteoporosis was induced through ovariectomy, dietary depletion of calcium and vitamin D, and steroid administration. After osteoporotic induction, lumbar vertebral body defect creation was performed. Sheep were randomly implanted with the control vehicle, comprised of hyaluronic acid (HA) with hydroxyapatite-coated β-tricalcium phosphate (β-TCP), or the treatment material of rhNELL-1 protein lyophilized onto β-TCP mixed with HA. Analysis of lumbar spine defect healing was performed by radiographic, histologic, and computer-simulated biomechanical testing.
RESULTS: rhNELL-1 treatment significantly increased lumbar spine bone formation, as determined by bone mineral density, % bone volume, and mean cortical width as assessed by micro-computed tomography. Histological analysis revealed a significant increase in bone area and osteoblast number and decrease in osteoclast number around the implant site. Computer-simulated biomechanical analysis of trabecular bone demonstrated that rhNELL-1-treatment resulted in a significantly more stress-resistant composition.
CONCLUSION: Our findings suggest rhNELL-1-based vertebral implantation successfully improved cortical and cancellous bone regeneration in the lumbar spine of osteoporotic sheep. rhNELL-1-based bone graft substitutes represent a potential new local therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27113550      PMCID: PMC4913506          DOI: 10.1089/ten.TEA.2015.0230

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  52 in total

1.  Biomechanical responses of the intervertebral joints to static and vibrational loading: a finite element study.

Authors:  Jason Tak-Man Cheung; Ming Zhang; Daniel Hung-Kay Chow
Journal:  Clin Biomech (Bristol, Avon)       Date:  2003-11       Impact factor: 2.063

Review 2.  Bone graft substitutes.

Authors:  Cato Laurencin; Yusuf Khan; Saadiq F El-Amin
Journal:  Expert Rev Med Devices       Date:  2006-01       Impact factor: 3.166

3.  Increased swelling complications associated with off-label usage of rhBMP-2 in the anterior cervical spine.

Authors:  Joseph D Smucker; John M Rhee; Kern Singh; S Tim Yoon; John G Heller
Journal:  Spine (Phila Pa 1976)       Date:  2006-11-15       Impact factor: 3.468

Review 4.  The potential of gene therapy for fracture healing in osteoporosis.

Authors:  M Egermann; E Schneider; C H Evans; A W Baltzer
Journal:  Osteoporos Int       Date:  2005-01-15       Impact factor: 4.507

5.  Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion.

Authors:  Lisa B E Shields; George H Raque; Steven D Glassman; Mitchell Campbell; Todd Vitaz; John Harpring; Christopher B Shields
Journal:  Spine (Phila Pa 1976)       Date:  2006-03-01       Impact factor: 3.468

6.  Percutaneous vertebroplasty treatment of steroid-induced osteoporotic compression fractures.

Authors:  J M Mathis; M Petri; N Naff
Journal:  Arthritis Rheum       Date:  1998-01

Review 7.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

Review 8.  Safety profile for the clinical use of bone morphogenetic proteins in the spine.

Authors:  Ashley R Poynton; Joseph M Lane
Journal:  Spine (Phila Pa 1976)       Date:  2002-08-15       Impact factor: 3.468

9.  NELL-1 in the treatment of osteoporotic bone loss.

Authors:  Aaron W James; Jia Shen; Xinli Zhang; Greg Asatrian; Raghav Goyal; Jin H Kwak; Lin Jiang; Benjamin Bengs; Cymbeline T Culiat; A Simon Turner; Howard B Seim Iii; Benjamin M Wu; Karen Lyons; John S Adams; Kang Ting; Chia Soo
Journal:  Nat Commun       Date:  2015-06-17       Impact factor: 14.919

10.  Morphological changes of injected calcium phosphate cement in osteoporotic compressed vertebral bodies.

Authors:  H D Heo; Y J Cho; S H Sheen; S U Kuh; S M Cho; S M Oh
Journal:  Osteoporos Int       Date:  2009-12       Impact factor: 4.507

View more
  9 in total

Review 1.  Preclinical and Translational Studies in Small Ruminants (Sheep and Goat) as Models for Osteoporosis Research.

Authors:  Isabel R Dias; José A Camassa; João A Bordelo; Pedro S Babo; Carlos A Viegas; Nuno Dourado; Rui L Reis; Manuela E Gomes
Journal:  Curr Osteoporos Rep       Date:  2018-04       Impact factor: 5.096

2.  NELL1 Regulates the Matrisome to Promote Osteosarcoma Progression.

Authors:  Qizhi Qin; Mario Gomez-Salazar; Robert J Tower; Leslie Chang; Carol D Morris; Edward F McCarthy; Kang Ting; Xinli Zhang; Aaron W James
Journal:  Cancer Res       Date:  2022-08-03       Impact factor: 13.312

Review 3.  NELL-1 in Genome-Wide Association Studies across Human Diseases.

Authors:  Xu Cheng; Jiayu Shi; Zhonglin Jia; Pin Ha; Chia Soo; Kang Ting; Aaron W James; Bing Shi; Xinli Zhang
Journal:  Am J Pathol       Date:  2021-12-07       Impact factor: 5.770

Review 4.  Signaling network regulating osteogenesis in mesenchymal stem cells.

Authors:  Sachin Thomas; Bithiah Grace Jaganathan
Journal:  J Cell Commun Signal       Date:  2021-07-08       Impact factor: 5.782

5.  Application of Enhanced Recovery after Surgical Treatment of the Occipitocervical Region.

Authors:  Peng Liu; Hai Nie; Zhuan Wang; Bao Yao; Jia-Hong Li; Ji Zhou
Journal:  Orthop Surg       Date:  2021-05-05       Impact factor: 2.071

6.  Neural EGF-like protein 1 (NELL-1): Signaling crosstalk in mesenchymal stem cells and applications in regenerative medicine.

Authors:  Mikhail Pakvasa; Alex Alverdy; Sami Mostafa; Eric Wang; Lucy Fu; Alexander Li; Leonardo Oliveira; Aravind Athiviraham; Michael J Lee; Jennifer Moriatis Wolf; Tong-Chuan He; Guillermo A Ameer; Russell R Reid
Journal:  Genes Dis       Date:  2017-08-03

7.  Isolation and characterization of canine perivascular stem/stromal cells for bone tissue engineering.

Authors:  Aaron W James; Xinli Zhang; Mihaela Crisan; Winters R Hardy; Pei Liang; Carolyn A Meyers; Sonja Lobo; Venu Lagishetty; Martin K Childers; Greg Asatrian; Catherine Ding; Yu-Hsin Yen; Erin Zou; Kang Ting; Bruno Peault; Chia Soo
Journal:  PLoS One       Date:  2017-05-10       Impact factor: 3.240

8.  Comparative population genomic analysis uncovers novel genomic footprints and genes associated with small body size in Chinese pony.

Authors:  Hojjat Asadollahpour Nanaei; Ali Esmailizadeh; Ahmad Ayatollahi Mehrgardi; Jianlin Han; Dong-Dong Wu; Yan Li; Ya-Ping Zhang
Journal:  BMC Genomics       Date:  2020-07-20       Impact factor: 3.969

Review 9.  An overview of de novo bone generation in animal models.

Authors:  Takashi Taguchi; Mandi J Lopez
Journal:  J Orthop Res       Date:  2020-09-23       Impact factor: 3.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.